627 related articles for article (PubMed ID: 36958177)
1. Design and synthesis of novel arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines with antimicrobial activity against multidrug-resistant Gram-positive bacteria.
Canale V; Czekajewska J; Klesiewicz K; Papież M; Kuziak A; Witek K; Piska K; Niemiec D; Kasza P; Pękala E; Empel J; Tomczak M; Karczewska E; Zajdel P
Eur J Med Chem; 2023 May; 251():115224. PubMed ID: 36958177
[TBL] [Abstract][Full Text] [Related]
2. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Ueda Y; Sunagawa M
Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
5. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
Bai PY; Qin SS; Chu WC; Yang Y; Cui DY; Hua YG; Yang QQ; Zhang E
Eur J Med Chem; 2018 Jul; 155():925-945. PubMed ID: 29966917
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of synthetic 1,3-bis(aryloxy)propan-2-amines against Gram-positive bacteria.
Serafim MSM; Lavorato SN; Kronenberger T; Sousa YV; Oliveira GP; Dos Santos SG; Kroon EG; Maltarollo VG; Alves RJ; Mota BEF
Microbiologyopen; 2019 Nov; 8(11):e814. PubMed ID: 30773849
[TBL] [Abstract][Full Text] [Related]
8. Curcusinol from the fruit of Carex baccans with antibacterial activity against multidrug-resistant strains.
Liu T; Wang ZJ; Shi YZ; Tao R; Huang H; Zhao YL; Luo XD
J Ethnopharmacol; 2024 Jan; 318(Pt A):116892. PubMed ID: 37460030
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of aryl-4-guanidinomethylbenzoate and N-aryl-4-guanidinomethylbenzamide as new antibacterial agents: synthesis and bioactivity.
Yu WY; Yang LX; Xie JS; Zhou L; Jiang XY; Zhu DX; Muramatsu M; Wang MW
Acta Pharmacol Sin; 2008 Feb; 29(2):267-77. PubMed ID: 18215358
[TBL] [Abstract][Full Text] [Related]
14. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
15. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.
Wang J; Zhang H; Yan J; Zhang T
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):861-870. PubMed ID: 32102584
[TBL] [Abstract][Full Text] [Related]
16. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
17. 6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens.
Vergoz D; Nilly F; Desriac F; Barreau M; Géry A; Lepetit C; Sichel F; Jeannot K; Giard JC; Garon D; Chevalier S; Muller C; Dé E; Brunel JM
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239913
[TBL] [Abstract][Full Text] [Related]
18. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
Rybak MJ; Hershberger E; Moldovan T; Grucz RG
Antimicrob Agents Chemother; 2000 Apr; 44(4):1062-6. PubMed ID: 10722513
[TBL] [Abstract][Full Text] [Related]
20. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
